Zomedica (ZOM) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
1 Feb, 2026Strategic focus and technology innovation
Advancing animal health through practical innovation and expanding digital capabilities, with a focus on technology and digital innovation to drive growth, improve clinical outcomes, and strengthen practice economics.
Emphasis on five pillars: improving pet care quality, enhancing pet parent satisfaction, streamlining veterinary workflow, supporting veterinarian cash flow, and increasing clinic profitability.
Investment in AI, connected devices, cloud platforms, and interpretation tools to create integrated product experiences and data-driven insights.
Market trends and digital transformation
AI adoption in animal health is projected to grow at an 18% CAGR, with the market reaching nearly $7 billion by 2033.
Pet tech spending and telehealth are rapidly expanding, with integrated health platforms combining in-clinic and at-home data becoming the industry standard.
Zomedica's digital transformation includes the MyZomedica platform, mobile apps, e-commerce, and over-the-air software updates, supporting scalable growth.
Product and platform development
Launched TRUVIEW AI for object detection and classification in diagnostics, and expanded VetGuardian onboarding and monitoring capabilities.
Utilization-based models and cloud-driven enhancements increase device lifetime value and recurring revenue.
PIMS integration targeted for completion by end of Q2, enabling seamless workflow and data exchange with veterinary clinics.
Latest events from Zomedica
- Profitability targeted for 2027, with strong R&D and product innovation fueling growth.ZOM
Status update27 Feb 2026 - Innovative veterinary solutions and recurring revenue drive high growth and margin expansion.ZOM
Small-Cap Growth Virtual Investor Conference1 Feb 2026 - Q2 revenue up 2% to $6.1M, but net loss surged on $16M impairment; margin reached 71%.ZOM
Q2 20241 Feb 2026 - Q3 revenue up 10% to $7M, 72% margin, net loss $6.7M, global expansion ongoing.ZOM
Q3 202415 Jan 2026 - Record $27.3M revenue, 70% margin, and strong liquidity set stage for 2025 growth.ZOM
Q4 202419 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and hold say-on-pay vote, with strong governance.ZOM
Proxy Filing2 Dec 2025 - Virtual annual meeting set for June 10; all shareholders urged to vote by June 8.ZOM
Proxy Filing2 Dec 2025 - Executive compensation for 2023 was updated to include full details for two key officers.ZOM
Proxy Filing2 Dec 2025 - Virtual annual meeting to vote on directors, auditor, and executive pay, with online access promoted.ZOM
Proxy Filing2 Dec 2025